CD99通过调节蛋白质合成来促进血造干细胞和白血病干细胞的自我更新
Yuanyuan Ji1, Yi Huang1, Toby Thomas1
1University of Texas at Dallas, United States.
Blood
|July 23, 2025
概括
CD99蛋白对于造血干细胞 (HSC) 和白血病干细胞 (LSC) 的自我更新至关重要. CD99的损失增加了蛋白质合成,损害了自我更新,可以通过抑制翻译来恢复.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 干细胞生物学 干细胞生物学
背景情况:
- 造血干细胞 (HSC) 维持血液的生产和自我更新.
- HSCs需要较低的蛋白质合成速率才能自我更新.
- 在压力和白血病发生过程中调节HSC蛋白质合成的机制尚不清楚.
研究的目的:
- 研究CD99在HSC和白血病干细胞 (LSC) 自更新中的作用.
- 确定CD99如何调节HSC和LSC中的蛋白质合成.
- 阐明CD99在急性髓性白血病 (AML) 发病过程中的功能.
主要方法:
- 在白血病干细胞 (LSCs) 中分析CD99表达.
- 研究CD99损失对HSC和LSC自我更新的影响.
- 评估具有CD99.9和没有CD99.9的HSC和LSC中的蛋白质合成率.
- 使用翻译抑制来恢复自我更新能力.
主要成果:
- 在急性髓性白血病 (AML) 中,CD99在白血病干细胞 (LSC) 中被上调.
- 在HSC和LSC中CD99的损失导致蛋白质合成的增加.
- 缺少CD99的HSC和LSC的自我更新受损,可以通过翻译抑制来挽救.
- CD99抑制蛋白质合成,可能导致AML的克隆扩张.
结论:
- CD99在调节HSC和LSC自我更新的蛋白质合成方面发挥着关键作用.
- 严格控制的蛋白质合成对HSC和LSC都至关重要.
- 通过调节蛋白质合成,CD99可能是AML的治疗点.
更多相关视频
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K
Maintenance of the ES Cell State
2.3K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.3K


